A Randomized, Prospective Trial of Robotic Versus Laparoscopic-assisted Radical Resection for Rectal Cancer in Urinary, Erectile Function and Anal Function
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Rectal Neoplasms
- Sponsor
- Southwest Hospital, China
- Enrollment
- 225
- Primary Endpoint
- Incidence of sexual and urinary dysfunction
- Last Updated
- 10 years ago
Overview
Brief Summary
This study compared robot-assisted total mesorectal excision (RTME) and laparoscopic total mesorectal excision (LTME) with regard to urinary function, sexual function and sphincter- preservation outcomes for low rectal cancer.
Detailed Description
Urinary and sexual dysfunction are recognized complications of rectal cancer surgery in men. This study compared robot-assisted total mesorectal excision (RTME) and laparoscopic total mesorectal excision(LTME) with regard to these functional outcomes.Sphincter- preservation outcomes for low rectal cancer was observed as well.
Investigators
Tang Bo
Principal Investigator
Southwest Hospital, China
Eligibility Criteria
Inclusion Criteria
- •Patients who are acceptable to two surgical procedures for the robot- assisted or laparoscopy-assisted rectal cancer, are willing to randomized trial;
- •Matching the diagnostic criteria;
- •Aged 18-70 years old;
- •Preoperative TNM staging (CT, laparoscopic exploration): cT1-3N0-3M0 (excluding M1, T4);
- •Preoperative ASA 3 scores;
- •There was no history of malignancy, no other malignant tumors by preoperative examination;
- •Without undergoing definitive treatment, such as radiotherapy, chemotherapy or immunotherapy preoperatively;
- •The informed consent form was signed by the patient himself(herself)or his principal agent;
- •In accordance with the international erectile function questionnaire (IIEF) urinary function scale, The urinary sexual function are normal.
Exclusion Criteria
- •Age less than 18 years old or more than 70 years old;
- •Previous psychiatric patients or patients refused to sign the informed consent;
- •Attending other related clinical studies on surgical treatment of rectal cancer;
- •The patient has a history of malignant tumor, or a combination of other malignant tumors;
- •Patients have been treated with definitive treatment: radiotherapy, chemotherapy or immunotherapy;
- •Patients had received otherper abdominal operations (except for laparoscopic cholecystectomy);
- •Laparoscopic surgical contraindications: such as severe heart lung disease; abdominal wall hernia; diaphragmatic hernia; coagulation disorder; portal hypertension; pregnancy, etc.;
- •Those who has been confirmed to be unable to do a radical resection (T4 stage) for local advanced tumor;
- •Those who have urination sexual dysfunction preoperatively.
Outcomes
Primary Outcomes
Incidence of sexual and urinary dysfunction
Time Frame: One years after surgery
Secondary Outcomes
- disease-free survival(DFS )(3 years disease-free survival)
- Anus preservation rate(One years after surgery)